Anesth Analg 2000;91:172-175
© 2000 International Anesthesia Research Society
OBSTETRIC ANESTHESIA
Prophylactic Intravenous Ondansetron Reduces the Incidence of Intrathecal Morphine-Induced Pruritus in Patients Undergoing Cesarean Delivery
Heui-Ming Yeh, MD,
Li-Kuei Chen, MD,
Chen-Jung Lin, MD,
Wei-Hung Chan, MD,
Yen-Po Chen, MD,
Chou-Shun Lin, MD,
Wei-Zen Sun, MD,
Ming-Jiuh Wang, MD, and
Shen-Kou Tsai, MD
Department of Anesthesiology, National Taiwan University Hospital, Taipei, Taiwan
Address correspondence and reprint requests to Li-Kuei Chen, MD, Department of Anesthesiology, National Taiwan University Hospital, No. 7, Chung-Shan South Rd., Taipei, Taiwan, 100.
Pruritus is a common side effect of intrathecal morphine injection for postoperative pain control. Its incidence is especially high in patients undergoing cesarean delivery. We investigated the effectiveness of ondansetron in preventing intrathecal morphine-induced pruritus in such patients. We included 60 consecutive nonbreastfeeding women who were scheduled for elective cesarean delivery. After the administration of spinal anesthesia with bupivacaine and intrathecal morphine 0.15 mg injection, the patients were randomly divided into three groups. Group 1 received placebo (normal saline) IV injection, Group 2 diphenhydramine 30 mg IV injection, and Group 3 ondansetron 0.1 mg/kg IV injection. The incidence of pruritus was significantly lower in the ondansetron group (25%) when compared with that in the placebo group (85%) and in the diphenhydramine group (80%) (both P < 0.05). The postoperative pain score and time to flatus passage were not significantly different among the three groups. There were no headache or extrapyramidal signs associated with ondansetron use. In conclusion, ondansetron prophylaxis significantly reduced the incidence of intrathecal morphine-induced pruritus in patients undergoing cesarean delivery.
Implications: Ondansetron prophylaxis significantly decreases the incidence of pruritus, a common side effect of intrathecal morphine used to treat postcesarean delivery pain.
This article has been cited by other articles:

|
 |

|
 |
 
D. Tamdee, S. Charuluxananan, Y. Punjasawadwong, C. Tawichasri, J. Patumanond, and P. Sriprajittichai
A Randomized Controlled Trial of Pentazocine Versus Ondansetron for the Treatment of Intrathecal Morphine-Induced Pruritus in Patients Undergoing Cesarean Delivery
Anesth. Analg.,
November 1, 2009;
109(5):
1606 - 1611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. George, T. K. Allen, and A. S. Habib
Serotonin Receptor Antagonists for the Prevention and Treatment of Pruritus, Nausea, and Vomiting in Women Undergoing Cesarean Delivery with Intrathecal Morphine: A Systematic Review and Meta-Analysis
Anesth. Analg.,
July 1, 2009;
109(1):
174 - 182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-P. Bonnet, E. Marret, J. Josserand, and F. J. Mercier
Effect of prophylactic 5-HT3 receptor antagonists on pruritus induced by neuraxial opioids: a quantitative systematic review
Br. J. Anaesth.,
September 1, 2008;
101(3):
311 - 319.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ganesh, A. Kim, P. Casale, and G. Cucchiaro
Low-Dose Intrathecal Morphine for Postoperative Analgesia in Children
Anesth. Analg.,
February 1, 2007;
104(2):
271 - 276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Siddik-Sayyid, M. T. Aouad, S. K. Taha, M. S. Azar, M. A. Hakki, R. N. Kaddoum, V. G. Nasr, V. G. Yazbek, and A. S. Baraka
Does Ondansetron or Granisetron Prevent Subarachnoid Morphine-Induced Pruritus After Cesarean Delivery?
Anesth. Analg.,
February 1, 2007;
104(2):
421 - 424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pirat, S. F. Tuncay, A. Torgay, S. Candan, and G. Arslan
Ondansetron, Orally Disintegrating Tablets Versus Intravenous Injection for Prevention of Intrathecal Morphine-Induced Nausea, Vomiting, and Pruritus in Young Males
Anesth. Analg.,
November 1, 2005;
101(5):
1330 - 1336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Iatrou, C. K. Dragoumanis, T. D. Vogiatzaki, G. I. Vretzakis, C. E. Simopoulos, and V. K. Dimitriou
Prophylactic Intravenous Ondansetron and Dolasetron in Intrathecal Morphine-Induced Pruritus: A Randomized, Double-Blinded, Placebo-Controlled Study
Anesth. Analg.,
November 1, 2005;
101(5):
1516 - 1520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Rathmell, T. R. Lair, and B. Nauman
The Role of Intrathecal Drugs in the Treatment of Acute Pain
Anesth. Analg.,
November 1, 2005;
101(5S_Suppl):
S30 - 43.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-D. Roy, M. Girard, and P. Drolet
Intrathecal Meperidine Decreases Shivering During Cesarean Delivery Under Spinal Anesthesia
Anesth. Analg.,
January 1, 2004;
98(1):
230 - 234.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Szarvas, R. S. Chellapuri, D. C. Harmon, J. Owens, D. Murphy, and G. D. Shorten
A Comparison of Dexamethasone, Ondansetron, and Dexamethasone plus Ondansetron as Prophylactic Antiemetic and Antipruritic Therapy in Patients Receiving Intrathecal Morphine for Major Orthopedic Surgery
Anesth. Analg.,
July 1, 2003;
97(1):
259 - 263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Charuluxananan, O. Kyokong, W. Somboonviboon, A. Narasethakamol, and P. Promlok
Nalbuphine Versus Ondansetron for Prevention of Intrathecal Morphine-Induced Pruritus After Cesarean Delivery
Anesth. Analg.,
June 1, 2003;
96(6):
1789 - 1793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Twycross, M.W. Greaves, H. Handwerker, E.A. Jones, S.E. Libretto, J.C. Szepietowski, and Z. Zylicz
Itch: scratching more than the surface
QJM,
January 1, 2003;
96(1):
7 - 26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Gurkan and K. Toker
Prophylactic Ondansetron Reduces the Incidence of Intrathecal Fentanyl-Induced Pruritus
Anesth. Analg.,
December 1, 2002;
95(6):
1763 - 1766.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|